Ellevest Inc’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Ellevest Inc’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29	Closed	-$1K	–	1769
2021 Q3	$1K	Buy	+29	New	+$801	﹤0.01%	1363

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Ellevest Inc's DRNA Position: Q4 2021 in Review

Ellevest Inc sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 29 shares — an estimated $1K sold.

Ellevest Inc first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Ellevest Inc reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Ellevest Inc sold 29 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1K.
Ellevest Inc first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
Ellevest Inc's Dicerna Pharmaceuticals, Inc. position peaked at $1K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.